AI stock-picking strategies rebalanced monthly, each with its backtested return against a benchmark.
S&P 500 stocks hand-picked by AI. The strategy studies all 500 constituents and selects the 20 most likely to outperform the market next month.
Analyses the 30 Dow blue chips, such as Goldman Sachs, Caterpillar and Visa, to find the 10 most likely to beat the market each month.
A portfolio of 15 leading tech stocks picked by algorithm each month, from big tech like NVIDIA, Apple and Microsoft to fast-growing software. Stay ahead of the latest tech trends.
The AI's 20 best Korean stocks this month, chosen from the 200 largest KOSPI companies on financial health, growth momentum and valuation.
Invests in Korea's leading healthcare companies, focusing on the biotech and pharmaceutical innovators such as Samsung Biologics, Celltrion and SK Biopharm.
Selects 20 high-growth mid caps with market caps of $2B to $10B, such as Axon, FICO and Deckers, each month. More growth potential than large caps.
Finds overlooked quality names like Berkshire Hathaway and Johnson & Johnson. The AI picks undervalued stocks at 15x earnings or less with room to rebound.
| Market | Benchmark | Risk | |||||||
|---|---|---|---|---|---|---|---|---|---|
IT15 Tech Titans | US | NASDAQ | +15.1% | +599.4% | +240.0% | 0.20 | 1.43 | High | 15 |
MM20 Market-Moving Mid Caps | US | Russell 2000 | +12.7% | +422.0% | +196.8% | 0.10 | 0.88 | Medium | 20 |
KRH15 Korean Pharma Rebound | Korea | KOSPI | +18.1% | +268.2% | +116.5% | 0.23 | 1.17 | Medium | 15 |
KOSPI20 Korea Market Leaders | Korea | KOSPI | +17.9% | +262.3% | +110.6% | 0.18 | 1.54 | High | 20 |
SP20 Beat the S&P 500 | US | S&P 500 | +11.2% | +332.8% | +107.5% | 0.10 | 2.03 | High | 20 |
DOW10 Beat the Dow Jones | US | Dow Jones | +10.8% | +315.6% | +90.3% | 0.36 | 1.40 | High | 10 |
US20 Top Value Stocks | US | S&P 500 | +9.8% | +264.3% | +39.0% | 0.37 | 0.80 | Low | 20 |